Edition:
United Kingdom

ITUS Corp (ITUS.OQ)

ITUS.OQ on NASDAQ Stock Exchange Capital Market

3.36USD
23 Feb 2018
Change (% chg)

$0.03 (+0.90%)
Prev Close
$3.33
Open
$3.35
Day's High
$3.46
Day's Low
$3.23
Volume
29,819
Avg. Vol
146,488
52-wk High
$6.42
52-wk Low
$0.60

Chart for

About

ITUS Corporation is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek cancer detection platform measures a patient's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that... (more)
No analyst recommendations are available for .

Overall

Beta: -1.11
Market Cap(Mil.): $42.44
Shares Outstanding(Mil.): 15.32
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 26.86 16.60
EPS (TTM): -- -- --
ROI: -- 9.18 10.66
ROE: -- 12.52 14.30

BRIEF-Lewis Titterton Reports 6.6 Pct Stake In Itus Corp As Of Feb. 14, 2018

* LEWIS H. TITTERTON REPORTS 6.6 PERCENT STAKE IN ITUS CORP AS OF FEBRUARY 14, 2018 - SEC FILING‍​ Source text (http://bit.ly/2CoeRLH) Further company coverage:

15 Feb 2018

BRIEF-Itus Corporation Terminates At-The-Market Offering

* ‍TERMINATED ITS AT-THE-MARKET EQUITY PROGRAM WITH B. RILEY FBR INC​ Source text for Eikon: Further company coverage:

12 Dec 2017

BRIEF-Itus enters into 2-year collaboration agreement

* Itus Corp - ‍on Nov 17, co, through unit entered into a 2 -year collaboration agreement with H. Lee Moffitt Cancer Center And Research Institute​

22 Nov 2017

BRIEF-ITUS Corp licenses CAR-T technology from Wistar Institute

* ITUS Corporation licenses CAR-T technology from the Wistar Institute

14 Nov 2017

BRIEF-ITUS Corp files for stock shelf offering of up to $24 mln

* ITUS Corp - files for stock shelf offering of up to $24 million - SEC filing‍​ Source text: (http://bit.ly/2yrgcTm) Further company coverage:

16 Oct 2017

BRIEF-Itus corp - ‍entered at-market issuance sales agreement with fbr capital to create equity program to sell up to $3.7 million common stock​

* Entered at-the-market issuance sales agreement with FBR capital to create equity program to sell up to $3.7 million common stock​ Source text for Eikon: Further company coverage:

29 Sep 2017

BRIEF-ITUS provides update on cancer detection technology and new CAR-T initiative for ovarian cancer

* ITUS provides update on cancer detection technology and new CAR-T initiative for ovarian cancer

21 Sep 2017

BRIEF-Itus Corporation announces issuance of patent on cancer detection technology

* Itus Corporation announces issuance of patent on cancer detection technology

18 Sep 2017

Earnings vs. Estimates

No consensus analysis data available.